Natural killer cells now have a better shot at destroying cancer

A cutting-edge immunotherapy is getting a boost from 3D-printing.

A new 3D-printing-based approach could unleash a cutting-edge immunotherapy against solid tumors, which account for 90% of all cancers.

Natural killers: Some immune system cells only know to attack a threat if they’ve encountered it at least once before (or been instructed to attack it by other cells that have). Natural killer (NK) cells, however, can recognize diseased cells the first time they cross paths with them — and then alert other members of the immune system, too.

This makes them a valuable first-line defense against illness, but, unfortunately, cancer cells multiply too fast and NK cells die too quickly for them to outright stop many cancers from spreading.

The challenge: Recently, doctors have started exploring ways to take advantage of TK cells’ natural cancer-fighting abilities. Typically, this means tweaking cells in the lab (to live longer, for example), multiplying them, and then injecting them into a patient’s bloodstream.

“We expect to contribute to the treatment of cancer patients through this newly developed technology.”

Su A Park

In clinical trials, NK cell-based therapy has shown promise against blood cancers, but it hasn’t performed as well when administered to people who’ve had surgery to remove solid tumors (in an attempt to kill any remaining cancer cells that may have been missed).

Getting enough of the NK cells to reach the site of the removed tumor is one part of the problem. Helping them withstand the harsh environment around the site of the lingering tumor cells is another.

What’s new? To address these issues, researchers in South Korea developed a technique for encapsulating NK cells in a hydrogel that could be 3D printed into a porous shape and later implanted at the site of a removed tumor.

This gel was designed to develop additional, smaller holes over time, and as the NK cells were allowed to multiply in the lab, they’d be released from those “micropores” and clump together — this helped them multiply and remain viable.

In theory, the 3D-printed hydrogel would be implanted at the site of a patient’s removed tumor after the NK cells had multiplied enough. For their study, though, the researchers tested the tech on leukemia and solid tumor cells in the lab, where they did demonstrate the desired anti-cancer activity.

a diagram showing the 3D-printed hydrogels containing NK cells
Credit: Korea Institute of Machinery and Materials (KIMM)

Looking ahead: This is just the first step in development, but the researchers are hopeful their approach could help make NK cell-based immunotherapy a more effective treatment against solid tumors.

“This technology can help to significantly improve the functionality of NK cells that are used for cancer treatment,” said principal researcher Su A Park. “We expect to contribute to the treatment of cancer patients through this newly developed technology.”

We’d love to hear from you! If you have a comment about this article or if you have a tip for a future Freethink story, please email us at [email protected].

New study challenges long-held assumption about cancer
Genetic mutations may not be necessary for cancer to develop, challenging a long-held assumption about the disease.
Personalized cancer vaccines are having a moment
Personalized cancer vaccines were a recurring theme at the annual meeting of the American Association for Cancer Research in 2024.
Cancer vaccine for dogs appears to nearly double survival rate
Yale researchers have developed a cancer vaccine for dogs that appears to increase their 12-month survival rate from 35% to 60%.
3D-printed skin could heal wounds with less scarring
Penn State scientists have 3D-printed skin directly on top of open wounds — an achievement that could improve reconstructive surgery.
How the “powerhouse of the cell” could be cancer’s Achilles heel
Salk Institute researchers have found that rewiring mitochondria could make cancer cells visible to the immune system.
Up Next
An image depicting cellular activity with blue and red lights, used for assessing the risk of pancreatic cancer.
Subscribe to Freethink for more great stories